Protective effect of β-glucan against systemic Streptococcus pneumoniae infection in mice

被引:32
作者
Hetland, G
Ohno, N
Aaberge, IS
Lovik, M
机构
[1] Natl Inst Publ Hlth, Dept Environm Med, Oslo, Norway
[2] Tokyo Univ Pharm & Life Sci, Tokyo, Japan
[3] Natl Inst Publ Hlth, Dept Vaccinol, Oslo, Norway
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2000年 / 27卷 / 02期
关键词
beta-1,3-D-glucan; antimicrobial effect; Streptococcus pneumoniae;
D O I
10.1111/j.1574-695X.2000.tb01420.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antimicrobial effect of soluble beta-1,3-D-glucan from Sclerotinia sclerotiorum (SSG) was examined in mice experimentally infected intraperitoneally (i.p.) with Streptococcus pneumoniae serotypes 4 and 6B. SSG was administered i.p. either 3 days before challenge or 3-48 h after challenge. The number of bacteria in blood samples and the mouse survival rates were recorded. Pre-challenge SSG administration protected Jose-dependently against both S. pneumoniae type 4 and 6B infections. SSG injected 24 h post-challenge had a curative effect against type 6B but not type 4 pneumococcal infection. The data demonstrate that SSG administered systemically protects against pneumococcal infection in mice. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 27 条
[21]   Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan [J].
Soltys, J ;
Quinn, MT .
INFECTION AND IMMUNITY, 1999, 67 (01) :244-252
[22]  
SUDA M, 1995, BIOL PHARM BULL, V18, P772
[23]   TISSUE DISTRIBUTION OF INTRAPERITONEALLY ADMINISTERED (1-]3)-BETA-D-GLUCAN (SSG), A HIGHLY BRANCHED ANTITUMOR GLUCAN, IN MICE [J].
SUDA, M ;
OHNO, N ;
ADACHI, Y ;
YADOMAE, T .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (08) :417-426
[24]  
SUZUKI I, 1989, CHEM PHARM BULL, V37, P410
[25]  
TAGUCHI T, 1983, ADV EXP MED BIOL, V166, P181
[26]   Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells [J].
Vetvicka, V ;
Thornton, BP ;
Ross, GD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :50-61
[27]  
WILLIAMS DL, 1978, J RETICULOENDOTH SOC, V23, P479